A Drug-Drug Interaction (DDI) Study of LY3437943 in Obese Participants
Condition: Obesity Interventions: Drug: LY3437943; Drug: Midazolam; Drug: Warfarin; Drug: Caffeine Sponsor: Eli Lilly and Company Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 6, 2022 Category: Research Source Type: clinical trials